Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04359004 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04359004: Completed NA study, sponsored by University of California, Los Angeles.
NCT04359004 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04359004, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Vagus nerve stimulation (VNS) has been shown to be beneficial in multiple studies including heart failure. The goal of this clinical investigation is to gain additional information about how vagus nerve stimulation relates to abnormal heart rhythms. The outcomes of this study will help researchers design new therapies for patients that have complex and life-threatening ventricular arrhythmias.
Interventions
- OTHER Vagus Nerve Stimulation (VNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-12-08 |
| Est. Completion | 2023-10-30 |
| Phase | NA |
What the finished NCT04359004 record still lists
NCT04359004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Vagus Nerve Stimulation (VNS) is the first listed.
NCT04359004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04359004 about?
NCT04359004 is a clinical study titled "A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation". Vagus nerve stimulation (VNS) has been shown to be beneficial in multiple studies including heart failure. The goal of this clinical investigation is to gain additional information about how vagus nerve stimulation relates to abnormal heart rhythms. The outcomes of this study will help researchers d...
What is the current status of trial NCT04359004?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-12-08. Estimated completion is 2023-10-30.
What interventions are being tested in trial NCT04359004?
The interventions under investigation include: Vagus Nerve Stimulation (VNS) (OTHER).
Who is sponsoring clinical trial NCT04359004?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04359004's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI